work hard PLAY HARD
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't get it. Company is going to dilute shares of a 5 Million $$ market cap and its still running. what am i missing?
Hepion Pharmaceuticals to Participate in ACS-JPS Webinar on AI Drug Development
EDISON, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of fibrotic diseases, including non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic diseases, announces that its Chief Executive Officer, Robert Foster, PharmD, PhD, and its Senior Vice President for Clinical Pharmacology and Analytics, Patrick Mayo, PhD, will be presenting during a webinar entitled “How Artificial Intelligence is Changing Drug Discovery” on Thursday, March 23rd at 1:00 p.m. Eastern Time.
https://finance.yahoo.com/news/hepion-pharmaceuticals-participate-acs-jps-201000894.html
I’m out in the field today can’t do it till tonight
Yes my bad. I was just going over it again to make sure
Updates on Ongoing Phase 2 NASH Clinical Program with Rencofilstat from the 6th Global NASH Congress
https://hepionpharma.com/wp-content/uploads/2023/01/NASH_TAG_2023_Final.pdf
It's 4:pm now in England. Will we get results before or after today's market close ?
I say this afternoon
No more dumping. This stock is actually trading now
Hmmm, No news on the contract posted to their web sight.
This has 10% for the big guy written all over it. But what the hell, lets take it for a ride
Thanks! ppl been trying to talk me back into it for years. Getting older and slowing down so i feel like its time to get back in. was on this all day
FDA fast track
lol, where's the other 15 mil coming from
whats going on?
Hepion Pharmaceuticals to Ring the NASDAQ Stock Market Closing Bell on February 10, 2023
https://finance.yahoo.com/news/hepion-pharmaceuticals-ring-nasdaq-stock-211500723.html
Was looking for a big dip today and it kept going. Very surprised, RSI now at 88
maybe Tuesday
Gonna hit the 10's today
HEPA up 10% what’s going on???
https://finance.yahoo.com/news/pds-biotech-announces-clinical-trial-130000756.html
GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® and Infectimune™ T-cell activating technologies, today announced the initiation of an Investigator-Initiated Trial (ITT), MC200710, for PDS0101 alone or in combination with the checkpoint inhibitor, KEYTRUDA®, in patients with HPV-associated oropharyngeal cancer (HPV(+)OPSCC) at high risk of recurrence. The trial is being led by Drs. David Routman, Katharine Price, Kathryn Van Abel, and Ashish Chintakuntlawar of Mayo Clinic, a nationally and internationally recognized center of excellence for the treatment of head and neck cancers.
GAP FILLED!
Over sold, i hope so
Someone Big is pounding this stock. A group with some heavy hitters. several 10K blocks
It's a damn shame. Wasting all these good pr's at this point. Any other stock would run to at least $10.plus on this press
It’s a keeper
Enjoying the ride yet
BREAKOUT!
Thats the 2nd time we had a 15.99 close. i still want to see it close over 16.00 RSI at 66 that could be a good launchpad
Woo Hooo!
Additional Phase IIa Data Confirms Hepion's CRV431 As A Very Promising NASH Candidate Drug
Sep. 21, 2021 4:19 PM ET Hepion Pharmaceuticals, Inc. (HEPA)
https://seekingalpha.com/article/4456410-additional-phase-iia-data-confirms-hepions-crv431-as-a-very-promising-nash-candidate-drug?mail_subject=francisco-javier-garcia-additional-phase-iia-data-confirms-hepion-s-crv431-as-a-very-promising-nash-candidate-drug&utm_campaign=rta-author-article&utm_content=link-0&utm_medium=email&utm_source=seeking_alpha
Given the direct relationship that the level of the Pro-C3 biomarker has with liver fibrosis, we are going to compare the behavior of the Pro-C3 biomarker in different trials carried out by companies with candidate drugs for NASH and thus be able to determine if the data provided by Hepion is promising.
Compared to the blood bath the rest of the markets had today I think PDS held its ground pretty well.
With some really good news too. We move forward
I think the reason for all the delays and cancellations of the board meeting is because they didn’t have the votes to do it.
I could wait out the seller. But now their going to vote on adding 200 mil. Shares. What the hell is the CFO thinking?!
Diluted. I’ve been watching the seller holding it down.
I posted it last weekend
I’m working in the field today. Can you do a play by play?